title: Recessive Dystrophic Epidermolysis Bullosa: Advances in the Laboratory Leading to New Therapies.
authors.affiliation: Department of Dermatology, Keck School of Medicine, University of Southern California, Los Angeles, California, USA. Electronic address: dwoodley@med.usc.edu.
authors.forename: David T
authors.initials: DT
authors.lastname: Woodley
authors.affiliation: Department of Dermatology, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
authors.forename: Mei
authors.initials: M
authors.lastname: Chen
mesh_terms: D064591:Allografts; D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D015331:Cohort Studies; D024143:Collagen Type VII / Q000235:genetics*; D004195:Disease Models, Animal; D016108:Epidermolysis Bullosa Dystrophica / Q000175:diagnosis / Q000235:genetics* / Q000628:therapy*; D005260:Female; D005808:Genes, Recessive / Q000235:genetics*; D020022:Genetic Predisposition to Disease; D015316:Genetic Therapy / Q000379:methods*; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods; D006801:Humans; D007753:Laboratories; D008297:Male; D051379:Mice; D009154:Mutation; D011379:Prognosis; D035583:Rare Diseases; D018570:Risk Assessment; D012720:Severity of Illness Index; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents; C569053:COL7A1 protein, human; D024143:Collagen Type VII